ATE145236T1 - Für die infektiöse erkrankung der bursa fabricius verantwortlicher virus - Google Patents

Für die infektiöse erkrankung der bursa fabricius verantwortlicher virus

Info

Publication number
ATE145236T1
ATE145236T1 AT90915645T AT90915645T ATE145236T1 AT E145236 T1 ATE145236 T1 AT E145236T1 AT 90915645 T AT90915645 T AT 90915645T AT 90915645 T AT90915645 T AT 90915645T AT E145236 T1 ATE145236 T1 AT E145236T1
Authority
AT
Austria
Prior art keywords
virus
infectious disease
virus responsible
fabricius
bursa
Prior art date
Application number
AT90915645T
Other languages
English (en)
Inventor
David Snyder
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Application granted granted Critical
Publication of ATE145236T1 publication Critical patent/ATE145236T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/36—Vegetable material
    • A21D2/364—Nuts, e.g. cocoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT90915645T 1989-10-18 1990-09-27 Für die infektiöse erkrankung der bursa fabricius verantwortlicher virus ATE145236T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42375789A 1989-10-18 1989-10-18

Publications (1)

Publication Number Publication Date
ATE145236T1 true ATE145236T1 (de) 1996-11-15

Family

ID=23680061

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90915645T ATE145236T1 (de) 1989-10-18 1990-09-27 Für die infektiöse erkrankung der bursa fabricius verantwortlicher virus

Country Status (10)

Country Link
EP (1) EP0496787B1 (de)
JP (1) JPH05504049A (de)
AT (1) ATE145236T1 (de)
AU (1) AU6605190A (de)
CA (1) CA2067397A1 (de)
DE (1) DE69029145T2 (de)
ES (1) ES2095258T3 (de)
NZ (1) NZ235474A (de)
WO (1) WO1991005569A1 (de)
ZA (1) ZA908260B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103939A (en) * 1992-12-01 1996-09-12 Abic Ltd An anti-DBI vaccine in birds containing attenuated live DBI virus
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts
EP0861665A1 (de) 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Vakzine gegen Infektiöse Bursitis
US6231868B1 (en) 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts
KR101172921B1 (ko) 2004-03-12 2012-08-13 와이어쓰 엘엘씨 감염성 점액낭병 바이러스 항원 분리체 및 백신

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US5064646A (en) * 1988-08-02 1991-11-12 The University Of Maryland Novel infectious bursal disease virus
US4956452A (en) * 1987-06-14 1990-09-11 The University Of Maryland Monoclonal antibody which neutralizes multiple strains of infectious bursal disease virus

Also Published As

Publication number Publication date
ES2095258T3 (es) 1997-02-16
EP0496787A4 (en) 1993-04-28
DE69029145T2 (de) 1997-05-07
ZA908260B (en) 1991-08-28
EP0496787B1 (de) 1996-11-13
NZ235474A (en) 1992-12-23
DE69029145D1 (de) 1996-12-19
EP0496787A1 (de) 1992-08-05
JPH05504049A (ja) 1993-07-01
CA2067397A1 (en) 1991-04-19
AU6605190A (en) 1991-05-16
WO1991005569A1 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
ATE136788T1 (de) Neues virus, verantwortlich für die infektiöse erkrankung der bursa fabricius
BR9306984A (pt) Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
SE9102975L (sv) Bakterofag och vaerd till anvaendning foer framstaellning av hiv-proteiner och peptider
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
KR910012244A (ko) 톡소플라스마 곤디 항원, 이의 제조방법 및 이의 용도
ES2123558T3 (es) Antigenos peptidicos del vhc y procedimiento para la determinacion del vhc.
DE3889138D1 (de) Influenza-Impfstoff.
ATE145236T1 (de) Für die infektiöse erkrankung der bursa fabricius verantwortlicher virus
AR010794A1 (es) Vacuna para la vacunacion in ovo de aves de corral contra la enfermedad newcastle y uso del virus de la enfermedad newcastle en la preparacion de dichavacuna
NZ213303A (en) Plasmodium protein, dna sequence and vaccine
ES2074983T3 (es) Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.
ES2058113T3 (es) Metodo de preparacion y uso de antigenos de virus de leucemia felina.
DE68920345D1 (de) Lebendes Kombinationsvakzin.
ATE4282T1 (de) Verfahren zur herstellung von toxoplasmenbereitungen fuer die toxoplasmosediagnose und die so hergestellten bereitungen.
SE8803062D0 (sv) Sequential polypeptides endowed with immunological activity
ES2037795T3 (es) Procedimiento para la preparacion del antigeno hrpii de plasmodium falciparum sge2.
DE3884672D1 (de) Ein synthetisches Nonapeptid zur Verwendung als Adjuvant.
FI972658L (fi) Menetelmä rokotteen valmistamiseksi siipikarjan tarttuvaa bursaalitautia vastaan
SE8701294L (sv) Hiv-peptid
DD129805A1 (de) Verfahren zur herstellung von viruslebendimpfstoffen,insbesondere aujeszky-lebendimpfstoff
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
GROTH et al. Morphologically, and especially in terms of the amount of genetic material it carries, an influenza virus is a complex creature. If we take it to bits by treatment with some detergent, such as
EA199900726A1 (ru) Синтетические hiv gag гены
ES8801959A1 (es) Un procedimiento para ensayos de sangre humana respecto de la presencia de anticuerpos frente al agente etiologico viral de sida
MX9706267A (es) Antigeno de helicobacter pylori.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties